GlobalData on MSN1d
Spinogenix reports top line outcomes from trial of therapy for Fragile X syndromeUS-based biopharmaceutical company Spinogenix has published top line outcomes from a Phase II trial of SPG601 for treating ...
Hosted on MSN1mon
Everything you need to know about Fragile X syndromeFragile X Society, the charity leading this call to ... and flat feet – which usually become more noticeable in young adults than in children and in males more than females,” says Richardson.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback